iBio, AstralBio Collab on Obesity Drug Discovery
April 8, 2024
Biotech firm iBio (NYSEA:IBIO) has incorporated EngageTx, a machine learning-driven technology, into its development roadmap.
In transitioning from CDMO and cGMP biologics manufacturing to a AI-powered biotechnology company, iBio has changed leadership and location as part of their mission to become a stalwart in developing antibodies for hard-to-drug targets